In the context of cancer, several studies have been published indicating that overexpression of Adora1 (adenosine A1 receptor) promotes the malignant progression of colorectal, renal, and breast cancers, as well as glioblastomas and leukemias (69). The gene discussed is ADORA1; the disease is leukemia.